Elite PharmaceuticalsELTP
13F holders, Q1 2025 (March 31)1holders
$0.43avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Elite Pharmaceuticals Inc. (ELTP) in their 13F filings. The largest holder was Ancora Advisors LLC ($2K).
- Company
- Elite Pharmaceuticals Inc.
- CUSIP
- 28659T200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 0 | $0 |
Ownership 1 holders
| Ancora Advisors LLC | 0.00% | New | 5,182 | $2K |
"% of holder's portfolio" is ELTP's weight in each manager's 13F, not the share of Elite Pharmaceuticals Inc. the manager owns.